Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in Glioblastoma stem-like cells

To identify therapeutic targets for Glioblastoma (GBM), we performed genome-wide CRISPR-Cas9 "knockout" (KO) screens in patient-derived GBM stem-like cells (GSCs) and human neural stem/progenitors (NSCs), non-neoplastic stem cell controls, for genes required for their in vitro growth. Surp...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Rep
Asıl Yazarlar: Toledo, Chad M., Ding, Yu, Hoellerbauer, Pia, Davis, Ryan J., Basom, Ryan, Girard, Emily J., Lee, Eunjee, Corrin, Philip, Hart, Traver, Bolouri, Hamid, Davison, Jerry, Zhang, Qing, Hardcastle, Justin, Aronow, Bruce J., Plaisier, Christopher L., Baliga, Nitin S., Moffat, Jason, Lin, Qi, Li, Xiao-Nan, Nam, Do-Hyun, Lee, Jeongwu, Pollard, Steven M., Zhu, Jun, Delrow, Jeffery J., Clurman, Bruce E., Olson, James M., Paddison, Patrick J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4691575/
https://ncbi.nlm.nih.gov/pubmed/26673326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2015.11.021
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller